×
About 213,994 results

ALLMedicine™ Hepatitis Center

Research & Reviews  100,977 results

Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepat...
https://doi.org/10.1186/s12879-021-05777-6 10.1038/ni875 10.1038/ni873 10.1038/srep16037 10.1038/ng.449 10.1053/j.gastro.2010.07.058 10.1038/nature08463 10.1053/j.gastro.2009.12.056 10.1128/JCM.02139-10 10.1038/ng.2521 10.1111/jgh.12902 10.1016/j.ajpath.2015.11.027 10.1073/pnas.1602319113 10.4103/1735-1995.189678 10.1093/infdis/jit433 10.1084/jem.20130012 10.1097/QAD.0000000000000052 10.3389/fcimb.2019.00340 10.1016/j.jhep.2015.06.035 10.1038/ng.447 10.1016/j.humimm.2016.05.007 10.1093/infdis/jit827 10.3390/ijms21072583 10.3109/0886022X.2015.1061872 10.1016/j.jhep.2013.09.023 10.1152/ajprenal.00472.2015 10.1093/labmed/lmw060 10.1093/nar/gks1172 10.1093/nar/gkv1249 10.1093/nar/gkv1176 10.1016/j.cell.2014.08.009 10.1093/bioinformatics/btr064 10.1093/nar/gki063 10.1093/nar/gku989 10.1093/bioinformatics/bth457 10.1053/j.jrn.2011.10.020 10.3748/wjg.v23.i21.3815 10.1371/journal.pone.0031016 10.1038/s41435-020-00115-3 10.3390/cells8040305 10.4049/jimmunol.1700807 10.1089/jir.2013.0136 10.7554/eLife.42542 10.3350/cmh.2014.20.4.368 10.1002/hep.25575 10.1101/gr.229102 10.1158/1078-0432.CCR-18-1060 10.1089/jir.2018.0046
BMC Infectious Diseases; Grzegorzewska AE, Mostowska A et. al.

Jan 23rd, 2021 - In non-uremic subjects, IFNL4 rs368234815 predicts HCV clearance. We investigated whether rs368234815 is associated with spontaneous HCV clearance in haemodialysis patients and whether it is a stronger predictor of HCV resolution than the IFNL pol...

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in ...
https://doi.org/10.1186/s12954-020-00441-9 10.1016/S2468-1253(16)30181-9 10.1016/j.jhep.2006.05.013 10.1002/hep.26141 10.1097/QAI.0b013e3181f9c0b6 10.1016/S0140-6736(11)61097-0 10.1097/COH.0b013e328354131e 10.1515/sirius-2018-0016 10.1016/S0140-6736(13)61530-5 10.1016/S2214-109X(17)30375-3 10.1007/s12529-017-9634-7 10.1080/02791072.2016.1262568 10.1371/journal.pmed.1001663 10.5812/hepatmon.4332 10.1016/j.drugpo.2019.09.018 10.1186/s12954-019-0355-x 10.5812/hepatmon.37089 10.1016/j.jcv.2019.02.005 10.1016/j.drugpo.2010.04.006 10.1016/j.puhe.2018.04.011 10.1016/S0140-6736(06)69132-0 10.1093/ije/dyt243 10.1111/j.1360-0443.2009.02888.x 10.1111/j.1360-0443.2007.01912.x 10.1371/journal.pone.0151946 10.1371/journal.pmed.1002056 10.1016/j.ijid.2015.09.022 10.1016/j.addbeh.2018.11.043 10.15171/ijhpm.2014.71 10.1016/j.drugpo.2007.02.007 10.1097/ADM.0b013e3182659928 10.4103/0253-7184.55477 10.5812/hepatmon.58739 10.1097/ADM.0000000000000112 10.1080/14659891.2016.1245793 10.1080/09540121.2014.882485 10.1016/j.ijid.2009.03.002 10.1016/j.drugpo.2003.07.001 10.1111/tmi.13065 10.1007/s11524-009-9393-0 10.1371/journal.pone.0082230 10.1590/S1413-86702009000500008 10.1111/j.1469-0691.2010.03167.x 10.1186/1477-7517-10-41 10.3748/wjg.v11.i26.4085 10.1136/sextrans-2013-051201 10.1016/j.jiph.2009.01.001 10.1177/0956462413512806 10.3390/pathogens9060432 10.1016/j.drugpo.2007.04.004 10.1186/s12954-019-0298-2 10.1038/s41598-019-42810-w 10.1590/S0074-02762010000300009 10.1007/s40471-017-0108-x 10.1371/journal.pone.0212558 10.3748/wjg.v23.i20.3569 10.1086/427448 10.1186/2008-2231-20-73 10.1111/dar.12014 10.1111/add.13453 10.1177/0956462413512806 10.1111/ajad.12604 10.1371/journal.pone.0207681 10.5812/hepatmon.12411 10.3310/phr05050 10.5812/ircmj.13484 10.1016/j.drugpo.2019.05.005
Harm Reduction Journal; Rajabi A, Sharafi H et. al.

Jan 23rd, 2021 - Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (...

Mobilization of γδ T Cells and IL-10 Production at the Acute Phase of Hepatitis E Virus...
https://doi.org/10.4049/jimmunol.2000187
Journal of Immunology (Baltimore, Md. : 1950); Barragué H, Fontaine J et. al.

Jan 23rd, 2021 - Alterations in the γδ T cell compartment have been reported in immunocompromised individuals infected with hepatitis E virus (HEV)-g3. We now report the analysis of blood γδ T cells from acutely HEV-infected individuals in the absence of immunosup...

Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatit...
https://doi.org/10.1002/rmv.2216
Reviews in Medical Virology; Zeleke ED, Assefa DG et. al.

Jan 23rd, 2021 - Hepatitis B virus (HBV) infection caused by mother-to-child transmission (MTCT) continues to pose challenges to global health. This study aimed to assess the efficacy and safety of tenofovir disoproxil fumarate (TDF) for preventing HBV MTCT. PubMe...

Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chron...
https://doi.org/10.1111/jvh.13473
Journal of Viral Hepatitis; Kirino S, Tamaki N et. al.

Jan 23rd, 2021 - Carcinogenesis risk scores for chronic hepatitis B have been proposed, but it remains unclear whether these scores during nucleoside/nucleotide analogue (NA) therapy are useful for risk assessment. In this study, we examined changes of these score...

see more →

Guidelines  329 results

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.22980
JAMA , Krist AH et. al.

Dec 15th, 2020 - An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and part...

WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713641
Journal of Clinical Gastroenterology; Hamid S, Alvares da Silva MR et. al.

Nov 24th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the least deadly but most infectious coronavirus strain transmitted from wild animals. It may affect many organ systems. Aim of the current guideline is to delineate the effects of SA...

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor...
https://doi.org/10.1053/j.gastro.2020.08.063
Gastroenterology Dougan M, Wang Y et. al.

Oct 20th, 2020 - Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve ...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/32931216
American Family Physician;

Sep 15th, 2020 - Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Statement.|2020||prevention & control,

see more →

Drugs  359 results see all →

Clinicaltrials.gov  105,827 results

Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepat...
https://doi.org/10.1186/s12879-021-05777-6 10.1038/ni875 10.1038/ni873 10.1038/srep16037 10.1038/ng.449 10.1053/j.gastro.2010.07.058 10.1038/nature08463 10.1053/j.gastro.2009.12.056 10.1128/JCM.02139-10 10.1038/ng.2521 10.1111/jgh.12902 10.1016/j.ajpath.2015.11.027 10.1073/pnas.1602319113 10.4103/1735-1995.189678 10.1093/infdis/jit433 10.1084/jem.20130012 10.1097/QAD.0000000000000052 10.3389/fcimb.2019.00340 10.1016/j.jhep.2015.06.035 10.1038/ng.447 10.1016/j.humimm.2016.05.007 10.1093/infdis/jit827 10.3390/ijms21072583 10.3109/0886022X.2015.1061872 10.1016/j.jhep.2013.09.023 10.1152/ajprenal.00472.2015 10.1093/labmed/lmw060 10.1093/nar/gks1172 10.1093/nar/gkv1249 10.1093/nar/gkv1176 10.1016/j.cell.2014.08.009 10.1093/bioinformatics/btr064 10.1093/nar/gki063 10.1093/nar/gku989 10.1093/bioinformatics/bth457 10.1053/j.jrn.2011.10.020 10.3748/wjg.v23.i21.3815 10.1371/journal.pone.0031016 10.1038/s41435-020-00115-3 10.3390/cells8040305 10.4049/jimmunol.1700807 10.1089/jir.2013.0136 10.7554/eLife.42542 10.3350/cmh.2014.20.4.368 10.1002/hep.25575 10.1101/gr.229102 10.1158/1078-0432.CCR-18-1060 10.1089/jir.2018.0046
BMC Infectious Diseases; Grzegorzewska AE, Mostowska A et. al.

Jan 23rd, 2021 - In non-uremic subjects, IFNL4 rs368234815 predicts HCV clearance. We investigated whether rs368234815 is associated with spontaneous HCV clearance in haemodialysis patients and whether it is a stronger predictor of HCV resolution than the IFNL pol...

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in ...
https://doi.org/10.1186/s12954-020-00441-9 10.1016/S2468-1253(16)30181-9 10.1016/j.jhep.2006.05.013 10.1002/hep.26141 10.1097/QAI.0b013e3181f9c0b6 10.1016/S0140-6736(11)61097-0 10.1097/COH.0b013e328354131e 10.1515/sirius-2018-0016 10.1016/S0140-6736(13)61530-5 10.1016/S2214-109X(17)30375-3 10.1007/s12529-017-9634-7 10.1080/02791072.2016.1262568 10.1371/journal.pmed.1001663 10.5812/hepatmon.4332 10.1016/j.drugpo.2019.09.018 10.1186/s12954-019-0355-x 10.5812/hepatmon.37089 10.1016/j.jcv.2019.02.005 10.1016/j.drugpo.2010.04.006 10.1016/j.puhe.2018.04.011 10.1016/S0140-6736(06)69132-0 10.1093/ije/dyt243 10.1111/j.1360-0443.2009.02888.x 10.1111/j.1360-0443.2007.01912.x 10.1371/journal.pone.0151946 10.1371/journal.pmed.1002056 10.1016/j.ijid.2015.09.022 10.1016/j.addbeh.2018.11.043 10.15171/ijhpm.2014.71 10.1016/j.drugpo.2007.02.007 10.1097/ADM.0b013e3182659928 10.4103/0253-7184.55477 10.5812/hepatmon.58739 10.1097/ADM.0000000000000112 10.1080/14659891.2016.1245793 10.1080/09540121.2014.882485 10.1016/j.ijid.2009.03.002 10.1016/j.drugpo.2003.07.001 10.1111/tmi.13065 10.1007/s11524-009-9393-0 10.1371/journal.pone.0082230 10.1590/S1413-86702009000500008 10.1111/j.1469-0691.2010.03167.x 10.1186/1477-7517-10-41 10.3748/wjg.v11.i26.4085 10.1136/sextrans-2013-051201 10.1016/j.jiph.2009.01.001 10.1177/0956462413512806 10.3390/pathogens9060432 10.1016/j.drugpo.2007.04.004 10.1186/s12954-019-0298-2 10.1038/s41598-019-42810-w 10.1590/S0074-02762010000300009 10.1007/s40471-017-0108-x 10.1371/journal.pone.0212558 10.3748/wjg.v23.i20.3569 10.1086/427448 10.1186/2008-2231-20-73 10.1111/dar.12014 10.1111/add.13453 10.1177/0956462413512806 10.1111/ajad.12604 10.1371/journal.pone.0207681 10.5812/hepatmon.12411 10.3310/phr05050 10.5812/ircmj.13484 10.1016/j.drugpo.2019.05.005
Harm Reduction Journal; Rajabi A, Sharafi H et. al.

Jan 23rd, 2021 - Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (...

Mobilization of γδ T Cells and IL-10 Production at the Acute Phase of Hepatitis E Virus...
https://doi.org/10.4049/jimmunol.2000187
Journal of Immunology (Baltimore, Md. : 1950); Barragué H, Fontaine J et. al.

Jan 23rd, 2021 - Alterations in the γδ T cell compartment have been reported in immunocompromised individuals infected with hepatitis E virus (HEV)-g3. We now report the analysis of blood γδ T cells from acutely HEV-infected individuals in the absence of immunosup...

Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatit...
https://doi.org/10.1002/rmv.2216
Reviews in Medical Virology; Zeleke ED, Assefa DG et. al.

Jan 23rd, 2021 - Hepatitis B virus (HBV) infection caused by mother-to-child transmission (MTCT) continues to pose challenges to global health. This study aimed to assess the efficacy and safety of tenofovir disoproxil fumarate (TDF) for preventing HBV MTCT. PubMe...

Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chron...
https://doi.org/10.1111/jvh.13473
Journal of Viral Hepatitis; Kirino S, Tamaki N et. al.

Jan 23rd, 2021 - Carcinogenesis risk scores for chronic hepatitis B have been proposed, but it remains unclear whether these scores during nucleoside/nucleotide analogue (NA) therapy are useful for risk assessment. In this study, we examined changes of these score...

see more →

News  6,311 results

US Supreme Court Rebuffs Merck Appeal in Hepatitis C Patent Fight With Gilead
https://www.medscape.com/viewarticle/944303

Jan 19th, 2021 - (Reuters) - The U.S. Supreme Court on Tuesday rejected Merck & Co Inc's bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences Inc for infringing a patent in a dispute over a blockbuster hepatitis C treatment. Th...

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
https://www.medscape.com/viewarticle/944180

Jan 14th, 2021 - In an effort to counteract alarming trends in rising hepatitis infections, the U.S. Department of Health and Human Services has developed and released its Viral Hepatitis National Strategic Plan 2021-2025, which aims to eliminate viral hepatitis i...

HCV Declines Level Off in HIV+ Men Who Have Sex With Men
https://www.medscape.com/viewarticle/943804

Jan 10th, 2021 - NEW YORK (Reuters Health) - The incidence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals (DAAs) became universally available in 2015, new findings show. While...

Youth Depression Tied to a Wide Range of Illnesses, Early Death
https://www.medscape.com/viewarticle/942816

Dec 16th, 2020 - Children and adolescents with depression may be at dramatically increased risk for premature death or an array of diseases later in life, new research suggests. Youths with depression had a significantly increased risk for being diagnosed with any...

The Lifesaving Potential of Less-Than-Perfect Donor Kidneys
https://www.medscape.com/viewarticle/942848

Dec 16th, 2020 - This story was co-produced with Scientific American. "I have no reservations — none whatsoever — about getting a hepatitis C kidney," Price said in a follow-up phone call with Undark. Still, there are lingering concerns. On the one hand, Roth, the...

see more →

Patient Education  191 results see all →